Scilex Holding Company (SCLX)
NASDAQ·Healthcare·Drug Manufacturers - General
$6.92
+0.65%
Mkt Cap $73.29M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 10, 2026 | $12.10M | $12.10M | +0.00% | -$0.47 | -$4.60 | -878.72% | — | — |
| Q4 2025 Nov 14, 2025 | $12.10M | $10.56M | -12.73% | -$0.47 | -$22.17 | -4617.02% | — | — |
| Q3 2025 Aug 13, 2025 | $26.25M | $9.90M | -62.30% | -$0.41 | -$7.42 | -1709.76% | — | — |
| Q2 2025 May 14, 2025 | $5.00M | $5.00M | +0.00% | -$4.20 | -$2.26 | +46.19% | — | — |
| Q1 2025 Mar 31, 2025 | $17.79M | $14.90M | -16.24% | -$0.10 | -$0.25 | -150.00% | — | — |
| Q1 2025 Jan 17, 2025 | $17.87M | $14.44M | -19.21% | -$0.17 | -$6.29 | -3600.00% | — | — |
| Q3 2024 Aug 13, 2024 | $16.17M | $16.37M | +1.25% | -$6.99 | -$6.29 | +10.01% | — | — |
| Q2 2024 May 13, 2024 | $10.88M | $10.88M | +0.00% | -$4.20 | -$9.09 | -116.43% | — | — |
| Q1 2024 Mar 11, 2024 | $11.43M | $13.46M | +17.82% | -$7.34 | -$8.74 | -19.07% | — | — |
| Q4 2023 Nov 14, 2023 | $11.37M | $10.12M | -10.99% | -$5.94 | -$22.03 | -270.88% | — | — |
| Q3 2023 Aug 11, 2023 | — | $12.58M | — | — | -$5.59 | — | — | — |
| Q2 2023 May 12, 2023 | — | $10.58M | — | — | -$0.22 | — | — | — |
| Q1 2023 Mar 7, 2023 | — | $11.92M | — | — | -$4.66 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | $11.38M | — | — | $5.65 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $7.93M | — | — | -$4.42 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $6.81M | — | — | -$2.27 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | $8.26M | — | — | $0.26 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $8.32M | — | — | -$0.33 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $7.83M | — | — | -$4.51 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $7.83M | — | — | -$4.51 | — | — | — |